CD28/NN
costimulation/NN
augments/VBZ
IL-2/NN
secretion/NN
of/IN
activated/VBN
lamina/NN
propria/NN
T/NN
cells/NNS
by/IN
increasing/VBG
mRNA/NN
stability/NN
without/IN
enhancing/VBG
IL-2/NN
gene/NN
transactivation/NN
./.

The/DT
pathways/NNS
leading/VBG
to/TO
activation/NN
in/IN
lamina/NN
propria/NN
(/(
LP/NN
)/)
T/NN
cells/NNS
are/VBP
different/JJ
from/IN
peripheral/JJ
T/NN
cells/NNS
./.
=====
LP/NN
T/NN
cells/NNS
exhibit/VBP
enhanced/VBN
IL-2/NN
secretion/NN
when/WRB
activated/VBN
through/IN
the/DT
CD2/NN
pathway/NN
./.
=====
Coligation/NN
of/IN
CD28/NN
leads/VBZ
to/TO
synergistic/JJ
enhancement/NN
of/IN
IL-2/NN
secretion/NN
./.
=====
Previous/JJ
studies/NNS
have/VBP
characterized/VBN
the/DT
CD28/NN
augmentation/NN
of/IN
TCR-mediated/JJ
signaling/NN
in/IN
peripheral/JJ
blood/NN
T/NN
cells/NNS
through/IN
transcriptional/JJ
activation/NN
of/IN
an/DT
IL-2/NN
promoter/NN
CD28/NN
response/NN
element/NN
(/(
CD28RE/NN
)/)
,/,
along/IN
with/IN
enhanced/VBN
mRNA/NN
stability/NN
./.
=====
This/DT
study/NN
characterized/VBD
molecular/JJ
events/NNS
involved/VBN
in/IN
CD28/NN
costimulation/NN
of/IN
IL-2/NN
production/NN
in/IN
LP/NN
mononuclear/JJ
cells/NNS
(/(
LPMC/NN
)/)
./.
=====
LPMC/NN
exhibited/VBD
increased/VBN
IL-2/NN
production/NN
in/IN
response/NN
to/TO
CD28/NN
costimulation/NN
,/,
compared/VBN
with/IN
cells/NNS
activated/VBN
through/IN
CD2/NN
alone/RB
./.
=====
IL-2/NN
secretion/NN
was/VBD
paralleled/VBN
by/IN
increased/VBN
expression/NN
of/IN
IL-2/NN
mRNA/NN
,/,
resulting/VBG
from/IN
enhanced/VBN
IL-2/NN
mRNA/NN
stability/NN
./.
=====
In/IN
contrast/NN
to/TO
transcriptional/JJ
activation/NN
in/IN
PBMC/NN
,/,
EMSA/NN
revealed/VBD
that/IN
CD28/NN
coligation/NN
of/IN
CD2-activated/JJ
LPMC/NN
does/VBZ
not/RB
result/VB
in/IN
increased/VBN
binding/NN
of/IN
trans-factors/NNS
to/TO
the/DT
CD28RE/NN
,/,
nor/CC
did/VBD
Western/NN
blots/NNS
detect/VB
changes/NNS
in/IN
I-kappaBalpha/NN
or/CC
I-kappaBbeta/NN
levels/NNS
following/VBG
CD28/NN
coligation/NN
./.
=====
Furthermore/RB
,/,
CD28/NN
coligation/NN
fails/VBZ
to/TO
enhance/VB
IL-2/NN
promoter-reporter/NN
or/CC
RE/AP/NN
construct/NN
expression/NN
in/IN
CD2-activated/JJ
LPMC/NN
./.
=====
The/DT
results/NNS
reported/VBN
herein/RB
indicate/VBP
that/IN
the/DT
molecular/JJ
mechanisms/NNS
involved/VBN
in/IN
CD28/NN
cosignaling/NN
and/CC
regulation/NN
of/IN
IL-2/NN
secretion/NN
in/IN
LP/NN
T/NN
cells/NNS
are/VBP
unique/JJ
to/TO
that/DT
compartment/NN
and/CC
differ/VBP
from/IN
those/DT
seen/VBN
in/IN
peripheral/JJ
blood/NN
T/NN
cells/NNS
./.
=====
These/DT
observations/NNS
suggest/VBP
a/DT
biological/JJ
significance/NN
for/IN
different/JJ
mechanisms/NNS
of/IN
IL-2/NN
activation/NN
in/IN
initiation/NN
and/CC
maintenance/NN
of/IN
the/DT
cytokine/NN
repertoire/NN
found/VBN
in/IN
the/DT
mucosa/NN
./.